Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The term **collagen scaffold-University of Alabama at Birmingham** refers to the collagen-based biomaterials evaluated by the University of Alabama at Birmingham (UAB) for regenerative endodontic procedures, specifically for the regeneration of dental pulp tissue in necrotic immature permanent teeth. In clinical research led by UAB (notably trial NCT03318328), two primary scaffolds are investigated: **Syn-Oss**, a novel FDA-approved collagen-hydroxyapatite composite material, and **Colla-Plug**, a traditional absorbable collagen scaffold derived from bovine Achilles tendon. These scaffolds are placed within the disinfected root canal space to provide a three-dimensional structural matrix that supports the attachment, migration, and differentiation of mesenchymal stem cells. This process aims to restore pulpal vitality and promote continued root development (apexogenesis) in teeth that have lost vitality due to infection or trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen scaffold-University of Alabama at Birmingham.